Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)

Publication

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)

Journal Paper/Review - Oct 1, 2005

Ghielmini M, Cerny Thomas, Wernli M, Ketterer N, Lohri A, Stahel R, Martinelli G, Fey M, Cogliatti S, Léger-Falandry C, Leoncini-Franscini L, Salles G, Rufibach K, Schmitz S-F Hsu

Ghielmini, M

Rufibach, K

Salles, G

Leoncini-Franscini, L

Léger-Falandry, C

Cogliatti, S

Fey, M

Martinelli, G

Stahel, R

Lohri, A

Ketterer, N

Wernli, M

Cerny, Thomas

144

Schmitz, S-F Hsu